International Clinical Trial: Real-world study on the efficacy and safety of TEA in treating autoimmune gastrointestinal dysmotility and gastrointestinal dysfunction

Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134597) titled 'Real-world study on the efficacy and safety of TEA in treating autoimmune gastrointestinal dysmotility and gastrointestinal dysfunction' on Oct. 16.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Peking University First Hospital

Condition: autoimmune gastrointestinal dysmotility

Intervention: Study group:We will prospectively enroll AGID patients who visit our hospital, including tumor-related, immune-related, and idiopathic cases. General patient information, gastrointestinal symptoms, and quality of life will be collected and evaluated using relevant scoring scales. Routine di...